Skip Navigation

European Heart Journal 1989 10(Supplement E):41-47; doi:10.1093/eurheartj/10.suppl_E.41
Copyright © 1989 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Murtazam, A.
Right arrow Articles by Campbell, R. W. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murtazam, A.
Right arrow Articles by Campbell, R. W. F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1989 The European Society of Cardiology

Specific drugs for specific ventricular arrhythmias: an evaluation of current therapy and the role of propafenone

A. Murtazam and R. W. F. Campbell

Academic Cardiology, Freeman Hospital Newcastle-upon-Tyne, U.K.

Address for correspondence: A. Murtazam, Academic Cardiology, Freeman Hospital, Newcastle-upon-Tyne, NE7 7DN, UK

Drug management of ventricular arrhythmias follows few scientific principles. Specific therapy for specific arrhythmias must be a goal for the future. Already a few important arrhythmia subtypes demanding specific therapy have been identified. As new drugs become available, they may offer particular effects against identifiable clinical arrhythmias.

Key Words: Propafenone • ventricular arrhythmias • antiarrhythmic drugs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.